Book contents
- Frontmatter
- Dedication
- Contents
- List of Contributors
- Preface
- Part I Clinical syndromes: general
- Part II Clinical syndromes: head and neck
- Part III Clinical syndromes: eye
- Part IV Clinical syndromes: skin and lymph nodes
- Part V Clinical syndromes: respiratory tract
- Part VI Clinical syndromes: heart and blood vessels
- Part VII Clinical syndromes: gastrointestinal tract, liver, and abdomen
- Part VIII Clinical syndromes: genitourinary tract
- Part IX Clinical syndromes: musculoskeletal system
- Part X Clinical syndromes: neurologic system
- Part XI The susceptible host
- Part XII HIV
- Part XIII Nosocomial infection
- Part XIV Infections related to surgery and trauma
- Part XV Prevention of infection
- Part XVI Travel and recreation
- Part XVII Bioterrorism
- Part XVIII Specific organisms: bacteria
- Part XIX Specific organisms: spirochetes
- Part XX Specific organisms: Mycoplasma and Chlamydia
- Part XXI Specific organisms: Rickettsia, Ehrlichia, and Anaplasma
- Part XXII Specific organisms: fungi
- Part XXIII Specific organisms: viruses
- Part XXIV Specific organisms: parasites
- Part XXV Antimicrobial therapy: general considerations
- 205 Principles of antibiotic therapy
- 206 Antibacterial agents
- 207 Antifungal therapy
- 208 Antiviral therapy
- 209 Probiotics
- 210 Hypersensitivity to antibiotics
- 211 Antimicrobial agent tables
- Index
- References
206 - Antibacterial agents
from Part XXV - Antimicrobial therapy: general considerations
Published online by Cambridge University Press: 05 April 2015
Edited by
Book contents
- Frontmatter
- Dedication
- Contents
- List of Contributors
- Preface
- Part I Clinical syndromes: general
- Part II Clinical syndromes: head and neck
- Part III Clinical syndromes: eye
- Part IV Clinical syndromes: skin and lymph nodes
- Part V Clinical syndromes: respiratory tract
- Part VI Clinical syndromes: heart and blood vessels
- Part VII Clinical syndromes: gastrointestinal tract, liver, and abdomen
- Part VIII Clinical syndromes: genitourinary tract
- Part IX Clinical syndromes: musculoskeletal system
- Part X Clinical syndromes: neurologic system
- Part XI The susceptible host
- Part XII HIV
- Part XIII Nosocomial infection
- Part XIV Infections related to surgery and trauma
- Part XV Prevention of infection
- Part XVI Travel and recreation
- Part XVII Bioterrorism
- Part XVIII Specific organisms: bacteria
- Part XIX Specific organisms: spirochetes
- Part XX Specific organisms: Mycoplasma and Chlamydia
- Part XXI Specific organisms: Rickettsia, Ehrlichia, and Anaplasma
- Part XXII Specific organisms: fungi
- Part XXIII Specific organisms: viruses
- Part XXIV Specific organisms: parasites
- Part XXV Antimicrobial therapy: general considerations
- 205 Principles of antibiotic therapy
- 206 Antibacterial agents
- 207 Antifungal therapy
- 208 Antiviral therapy
- 209 Probiotics
- 210 Hypersensitivity to antibiotics
- 211 Antimicrobial agent tables
- Index
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Clinical Infectious Disease , pp. 1333 - 1343Publisher: Cambridge University PressPrint publication year: 2015
References
, , , . Does doxycycline protect against development of Clostridium difficile infection?Clin Infect Dis. 2012;55:615–620.CrossRefGoogle Scholar
, , , , eds. The Sanford Guide to Antimicrobial Therapy, 44th edn. Sperryville, VA: Antimicrobial Therapy, Inc.; 2014.Google Scholar
, , , et al. Fluoroquinolones and the risk of serious arrhythmia: a population-based study. Clin Infect Dis. 2012;55:1457–1465.CrossRefGoogle ScholarPubMed
, , , , . Azithromycin and the risk of cardiovascular death. N Engl J Med. 2012;366:1881–1890.CrossRefGoogle ScholarPubMed
, , . An evidence-based review of linezolid for the treatment of methicillin-resistant Staphylococcus aureus (MRSA): place in therapy. Core Evid. 2012;7:1–13.Google ScholarPubMed